Search results for "Coronavirus"
Latest studies look at ECMO, prone positioning, antibodies, remdesivir
Mortality rates have risen among patients getting extracorporeal membrane oxygenation (ECMO) for COVID-19, one study found, while two others offered more evidence of the benefits of proning. Additional new research supported the use of monoclonal antibodies and remdesivir.
https://acphospitalist.acponline.org/weekly/archives/2021/10/06/1.htm
6 Oct 2021
Latest research shows impact of COVID-19 on other health care
Hospitalizations for stroke and myocardial infarction, ED visits, cancer diagnoses, and trials for conditions other than COVID-19 all dropped during the pandemic, recent studies showed.
https://acphospitalist.acponline.org/weekly/archives/2020/08/12/1.htm
12 Aug 2020
Elevated risk of hospitalization, death after COVID-19 dwindles by six months
A hospitalization for COVID-19 carries higher mortality risk than one for flu for only 90 days, one study found, while another showed that veterans who had COVID-19 actually had lower mortality risk than matched uninfected peers in the subsequent six months to two years.
https://acphospitalist.acponline.org/archives/2023/08/23/free/elevated-risk-of-hospitalization-death-after-covid-19-dwindles-by-six-months.htm
23 Aug 2023
June 1, 2022
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2022/06/01/
COVID-19 research focuses on steroids, clots, hydroxychloroquine, zinc
Steroids' effects varied by C-reactive protein level, clots occurred despite prophylaxis, and hydroxychloroquine and zinc were ineffective for COVID-19, according to newly published studies.
https://acphospitalist.acponline.org/weekly/archives/2020/07/29/1.htm
29 Jul 2020
Recommendations, trials don't find benefit from hydroxychloroquine for COVID-19
New guidance from ACP and recent trials do not support the use of hydroxychloroquine for COVID-19, and a pharmacokinetic analysis showed potential problems with lopinavir/ritonavir therapy.
https://acphospitalist.acponline.org/weekly/archives/2020/05/20/1.htm
20 May 2020
New evidence on remdesivir, intubation timing, outcomes after COVID-19 hospitalization
Remdesivir showed limited benefits, antibiotics have been overused, and intubation timing doesn't matter, but postdischarge outcomes were reassuring and infectious diseases experts offered guidance on the use of antibody tests in recent COVID-19 news.
https://acphospitalist.acponline.org/weekly/archives/2020/08/26/1.htm
26 Aug 2020
10 tips for physician wellness and more pandemic coverage
The July ACP Hospitalist is online and in the mail, with tips from the front lines on surviving COVID-19, additional articles about the pandemic, and a special focus on care for inpatients with addiction.
https://acphospitalist.acponline.org/weekly/archives/2020/07/15/2.htm
15 Jul 2020
April 27, 2022
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2022/04/27/
Rise in HAIs during the pandemic, guidance on monoclonal antibodies for COVID-19
A new study found significant growth in health care-associated infections (HAIs), especially central line-associated bloodstream infections, during 2020, and the NIH offered advice on prioritization when monoclonal antibodies can't be given to all eligible patients.
https://acphospitalist.acponline.org/weekly/archives/2021/09/15/1.htm
15 Sep 2021